CVS Health Co. (NYSE:CVS) Shares Sold by Coerente Capital Management

Coerente Capital Management reduced its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 4.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 117,184 shares of the pharmacy operator's stock after selling 5,012 shares during the period. CVS Health makes up about 1.5% of Coerente Capital Management's holdings, making the stock its 21st largest position. Coerente Capital Management's holdings in CVS Health were worth $7,939,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in CVS. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health during the 4th quarter worth $28,000. Hopwood Financial Services Inc. purchased a new stake in shares of CVS Health in the 4th quarter worth about $29,000. McIlrath & Eck LLC boosted its position in shares of CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares in the last quarter. Financial Perspectives Inc boosted its position in shares of CVS Health by 137.5% in the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. boosted its position in shares of CVS Health by 112.1% in the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock worth $37,000 after buying an additional 437 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CVS. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Argus set a $77.00 price objective on shares of CVS Health in a research report on Tuesday, February 18th. Mizuho boosted their price objective on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Finally, Cowen reissued a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Two equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $74.75.

CVS Health Trading Up 0.9%

Shares of NYSE CVS traded up $0.62 on Thursday, reaching $66.34. 6,562,248 shares of the company traded hands, compared to its average volume of 11,007,899. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The company has a 50 day moving average of $65.11 and a 200 day moving average of $60.05. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $83.92 billion, a PE ratio of 18.13, a P/E/G ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the prior year, the company posted $1.31 EPS. The company's quarterly revenue was up 7.0% compared to the same quarter last year. On average, equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.01%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director now owns 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 1.22% of the company's stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.